Hostname: page-component-848d4c4894-sjtt6 Total loading time: 0 Render date: 2024-06-26T12:01:15.403Z Has data issue: false hasContentIssue false
  • English
  • Français

Insight, symptom severity and medication adherence in bipolar disorder

Published online by Cambridge University Press:  19 July 2023

A. Abdelhamid ,
M. Nokrou ,
S. Bounouh ,
S. Belbachir  and
A. Ouanass
A. Abdelhamid*
Affiliation:
Psychiatry, Psychatric hospital Arrazi of Salé, Rabat, Morocco
M. Nokrou
Affiliation:
Psychiatry, Psychatric hospital Arrazi of Salé, Rabat, Morocco
S. Bounouh
Affiliation:
Psychiatry, Psychatric hospital Arrazi of Salé, Rabat, Morocco
S. Belbachir
Affiliation:
Psychiatry, Psychatric hospital Arrazi of Salé, Rabat, Morocco
A. Ouanass
Affiliation:
Psychiatry, Psychatric hospital Arrazi of Salé, Rabat, Morocco
*
*Corresponding author.

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

Bipolar disorder is a mood disorder that requires adequate treatment, both acutely and for long-term prevention to avoid recurrence. A growing number of safe and effective medications, particularly thymoregulatory drugs and antipsychotics, can be used for the preventive and long-term treatment of bipolar disorder.

Insight, or awareness of the illness, has been little studied in bipolar disorder. It would seem that the presence of psychotic symptoms and manic polarity are linked to an alteration in clinical insight. The lack of insight could be linked to poor or non-adherence to treatment in psychiatric pathology including bipolar disorder.

Objectives

Our aim is to study the correlation between the level of insight, symptom severity, and medication adherence in patients with bipolar disorder and compare them to those in the literature in order to allow a better therapeutic compliance for patients.

Methods

It is a prospective descriptive study of a series of cases, carried out at the psychiatric hospital Ar-razi in Salé over a period of 4 months.

Our inclusion criteria are patients diagnosed with bipolar disorder according to DSM 5 criteria, aged over 18 years.

The data are collected during the psychiatric interview with the patient. Insight is assessed by the Beck Cognitive Insight Scale and the severity of the symptoms is assessed by the Clinical Global Impression.

Results

Ongoing

Conclusions

Ongoing

Disclosure of Interest

None Declared

Type
Abstract
Information
European Psychiatry , Volume 66 , Special Issue S1: Abstracts of the 31st European Congress of Psychiatry , March 2023 , pp. S692
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
© The Author(s), 2023. Published by Cambridge University Press on behalf of the European Psychiatric Association
Submit a response

Comments

No Comments have been published for this article.